Ketanserin, a 5-HT antagonist, in symptomatic treatment of carcinoid syndrome.
D006801:Humans; D007650:Ketanserin / Q000627:therapeutic use*; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008875:Middle Aged
D007650:Ketanserin